pharma news today glp-1 obesity drug Some US employers to drop coverage of drugs in 2027 as use increases India Issues GLP-1 Drug Safety

Collectively, these studies provide evidence that the L-carnitine system is differentially impacted by APOE genotypes with age and following L-carnitine challenge which could later contribute to AD pathogenesis through bioenergetics deficits, FA toxicity, and cerebrovascular dysfunction in E4s, especially in females

Additionally, there have been case reports and anecdotal evidence suggesting that GLP-1 drugs can negatively impact mood

Current concepts on genetic aspects of mitochondrial dysfunction in amyotrophic lateral sclerosis

The MitoPrime peptide vial is the NAD+/MOTS-c/5-Amino-1MQ research product

Because glutathione protects cells so well, there is some concern that it could protect the very cells that medical treatments are trying to target